10-Q: Elite Health Systems Inc. Reports Q1 2025 Results; Focuses on Medicare Advantage Plan Development

Elite Health Systems Inc. reports a net loss for Q1 2025 as it continues to invest in developing its Medicare Advantage plan, Elite Health.

Summary

• Elite Health Systems Inc. reported a net loss of $424,000 for the three months ended March 31, 2025, compared to a net loss of $312,000 for the same period in 2024.
• The increased loss is primarily attributed to investments in Elite Health Plan prior to generating revenue.
• Selling, general, and administrative expenses decreased by 10% to $427,000 in Q1 2025, compared to $476,000 in Q1 2024, due to start-up costs for Elite Health Plan.
• The company had cash and cash equivalents of $3,696,000 as of March 31, 2025, compared to $4,034,000 as of December 31, 2024.
• The company's accumulated deficit increased to $4,869,000 as of March 31, 2025, from $4,445,000 as of December 31, 2024.
• The company is focused on obtaining a Knox-Keene license in California and securing necessary approvals from CMS for its Medicare Advantage plan.
• The company raised $5.8 million through a private placement of common stock to fund the development of its Medicare Advantage plan.
• As of April 30, 2025, the company had 21,409,924 shares of common stock outstanding.
• A note and line of credit was entered into on April 25, 2025 for $2,500,000 to aid in meeting tangible net equity requirements.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the increased net loss and accumulated deficit. However, the successful capital raise and ongoing efforts to develop the Medicare Advantage plan provide some positive aspects.

Positives

• The company successfully raised $5.8 million through a private placement to fund its Medicare Advantage plan development.
• Selling, general, and administrative expenses decreased by 10% in Q1 2025, indicating cost management efforts.
• Elite Health Plan is actively pursuing necessary licenses and approvals to operate a Medicare Advantage plan in California and Nevada.
• A note and line of credit was entered into on April 25, 2025 for $2,500,000 to aid in meeting tangible net equity requirements.

Negatives

• The company reported a net loss of $424,000 for Q1 2025, an increase from the $312,000 loss in Q1 2024.
• The company's accumulated deficit increased to $4,869,000 as of March 31, 2025.
• Elite Health Plan is currently in the development stage and generating no revenue.
• The company previously had a material weakness in internal control over financial reporting, although management believes this has been remediated.

Risks

• The company's ability to obtain necessary licenses and approvals for its Medicare Advantage plan is uncertain.
• The company's success depends on gaining access to a sufficient network of providers and enrolling a critical level of subscribers.
• The company's ability to continue as a going concern is dependent on its ability to manage costs and raise additional capital.
• The company operates in a highly competitive and rapidly changing environment.
• The company's financial condition and liquidity could be adversely affected by increased interest rates, construction delays, or other transactions, economic slowdowns, and changes in the company's plans, strategies, and intentions.

Future Outlook

The company intends to use the net proceeds from the private placement to execute the plan of Elite Health to establish a managed care organization that will operate as a Medicare Advantage plan for seniors.

Management Comments

• Management believes its plan alleviates the substantial doubt and that it will be successful in its planned business initiatives and will be able to continue as a going concern through at least the next twelve months.

Industry Context

The company is entering the competitive Medicare Advantage market, which is regulated by both federal and state governments. Success depends on obtaining licenses, building a provider network, and attracting subscribers.

Comparison to Industry Standards

• It is difficult to compare Elite Health Systems to industry standards as it is in the early stages of developing its Medicare Advantage plan and has not yet generated revenue.
• Companies like UnitedHealth Group, Humana, and CVS Health (Aetna) are established players in the Medicare Advantage market with significant resources and experience.
• Elite Health will need to demonstrate its ability to compete effectively in terms of cost, quality, and service to gain market share.

Related Party Transactions

• The Company recorded compensation with directors and officers of the Company for the year ended December 31, 2024 consisting of stock grants valued at $0.50 per share of 75,000 for each of directors St. Lawrence and Leimkuhler; 75,000 for our Executive Director and 250,000 for CEO and Board Chair, Dr. Jeereddi.
• The Company compensates Physician Support Services, Inc (PSS) for services of Executive Director and others as well as the sharing of rental space and other services; Dr. Jeereddi is the majority owner of PSS and our Executive Director is an employee.

Stakeholder Impact

• Shareholders: The increased net loss and accumulated deficit may negatively impact shareholder value.
• Employees: The company's ability to continue as a going concern could affect job security.
• Customers: The successful launch of the Medicare Advantage plan could provide seniors with access to comprehensive healthcare services.
• Suppliers: The company's financial stability could affect its ability to meet its obligations to suppliers.
• Creditors: The company's ability to repay its debts is dependent on its financial performance and ability to raise capital.

Next Steps

• Elite Health Plan will continue to pursue a Knox-Keene license in California and approvals from CMS.
• The company will focus on building a provider network and attracting subscribers for its Medicare Advantage plan.
• The company will manage costs and seek additional capital as needed to fund its operations and growth.

Key Dates

Keywords

Medicare Advantage, Elite Health, Knox-Keene license, CMS, Managed care, Healthcare, Financial results, Private placement, Net loss, Going concern